Table 1.

Willingness of patients to share pharmacogenomics (PGx) test results with family members and their health care providers (HCPs).

Are patients willing to manage PGx results? (Yes/No)	Number of participants	Findings	Rationale	Authors [Ref.]
Yes	1464	909 (62%) planned to share genomic results with HCPs	To improve health	van der Wouden et al. [12]
Yes	17	11 (65%) reported that they will share PGx results with physicians, 8 (47%) shared results with family	To select the best treatment option	Haga et al. [6]
Yes	588	406 (69%) planned to share PGx results with HCPs, family, children, siblings, friends, parents, and pharmacists	Results would be important for health care decisions and medication selection or family’s health	Olson et al. [11]
Yes	478	430 (90%) indicated that they were extremely comfortable sharing and managing PGx results	Wanted doctors to manage care and avoid duplicate testing	Haga et al. [14]
Yes	54	34 (63%) reported discussing PGx results with provider and 43 (80%) discussed results with family	To help in health care decision making	Lemke et al. [16]
Yes	77	56 (72.7%) reported sharing results from BRCA1/2 or Lynch syndrome testing with HCPs and 58 (75.3%) with family members	To inform family about risks, receive recommendations from HCPs	Taber et al. [15]
Yes	62	All participants wanted to share results with family and 37 (60%) with providers, while 20 (31%) wished to withhold PGx information from providers	Patients (n = 20, 31%) who did not want to share with providers claimed that providers were too busy, not interested, or incompetent	Madadi et al. [22]
Yes	319	249 (78%) viewed and navigated electronic health records but 70 (22%) patients did not want to see results	Patients (n = 70, 22%) who did not want to see PGx results expressed concerns for confidentiality, computer security, lack of interest, fear of results, etc.	Pyper et al. [21]